Last updated on November 2017

Mild Alzheimer's disease, Mild Cognitive Impairment or dementia


Brief description of study

Mild Alzheimer's disease, Mild Cognitive Impairment or dementia

Detailed Study Description

NeuroTrials Research is conducting a study to examine the effect of an investigational drug on sleep quality in patients with mild Alzheimer's Disease and cognitive impairment. All study-related care and study drug will be provided at no cost. Qualified participants and caregivers will be compensated for time and travel.

Patient Inclusion Criteria:
You may qualify if you:

  • are 50-80
  • have been diagnosed with Alzheimer’s Disease or mild cognitive impairment.
  • have a caregiver or study partner capable of attending all study visits.
  • are otherwise in good general health with no sleep disorders.

Clinical Study Identifier: TX16269

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Katy McNulty

NeuroTrials Research, Inc.
Atlanta, GA USA
  Connect »